C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 213/79 (2006.01) A61K 31/44 (2006.01) A61P 11/00 (2006.01) A61P 19/00 (2006.01) A61P 25/00 (2006.01) A61P 29/00 (2006.01) C07D 213/81 (2006.01) C07D 213/89 (2006.01)
Patent
CA 2475818
This invention relates to new aryl ureas of formula (I) and methods for their synthesis. The compounds are useful in the treatment of (i) raf mediated diseases, for example, cancer, (ii) p38 mediated diseases such as inflammation and osteoporosis, and (iii) VEGF mediated diseases such as angiogenesis disorders.
L'invention concerne des aryle-urées de formule (I) ainsi que des procédés destinés à les synthétiser. Ces composés sont utiles dans le traitement (i) de maladies à médiation raf, par exemple le cancer, (ii) de maladies à médiation p38 telles que l'ostéoporose et les affections inflammatoires, et (iii) de maladies à médiation VEGF telles que les troubles de l'angiogénèse.
Bjorge Susan
Chien Du-Shieng
Dumas Jacques
Lee Wendy
Musza Laszlo L.
Bayer Healthcare Llc
Bayer Pharmaceuticals Corporation
Smart & Biggar
LandOfFree
Aryl ureas as kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aryl ureas as kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryl ureas as kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1916295